$15.13
0.13[0.87%]
At close: Apr 19
$15.13
0[0.00%]
After Hours: 4:00PM EDT
Y-mAbs Therapeutics
(NASDAQ:YMAB)Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Earnings Estimates, EPS, and Revenue
Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.140
Quarterly Revenue Estimate
$23M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$84.8M
Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | PM | YMAB | Q1 | -$0.15 | -$0.14 | — | — | $20.25M | $22.97M | — | — | Get Alert |
| 02/29/2024 | PM | YMAB | Q4 | $0.03 | -$0.20 | -$0.02 | 90.00% | $31.45M | $20.95M | $23.36M | 11.52% | Get Alert |
| 11/13/2023 | PM | YMAB | Q3 | -$0.63 | -$0.19 | -$0.18 | 5.26% | $12.54M | $20.93M | $20.45M | -2.27% | Get Alert |
| 08/10/2023 | PM | YMAB | Q2 | -$0.94 | -$0.24 | -$0.14 | 41.67% | $10.80M | $20.35M | $20.75M | 1.97% | Get Alert |
| 05/08/2023 | PM | YMAB | Q1 | -$0.64 | -$0.32 | -$0.15 | 53.12% | $10.49M | $15.55M | $20.25M | 30.23% | Get Alert |
| 03/30/2023 | PM | YMAB | Q4 | -$0.85 | -$0.46 | $0.03 | 106.52% | $9.60M | $20.06M | $31.45M | 56.76% | Get Alert |
| 11/07/2022 | PM | YMAB | Q3 | -$0.66 | -$0.71 | -$0.63 | 11.27% | $8.96M | $12.01M | $12.54M | 4.39% | Get Alert |
| 08/08/2022 | PM | YMAB | Q2 | -$0.53 | -$0.69 | -$0.94 | -36.23% | $10.95M | $11.22M | $10.80M | -3.77% | Get Alert |
| 05/09/2022 | PM | YMAB | Q1 | $0.75 | -$0.72 | -$0.64 | 11.11% | $5.38M | $10.90M | $10.49M | -3.80% | Get Alert |
| 02/24/2022 | PM | YMAB | Q4 | -$0.48 | -$0.70 | -$0.85 | -21.43% | $20.75M | $10.82M | $9.60M | -11.29% | Get Alert |
| 11/04/2021 | PM | YMAB | Q3 | -$0.82 | -$0.60 | -$0.66 | -10.00% | $0.00 | $10.87M | $8.96M | -17.53% | Get Alert |
| 08/05/2021 | PM | YMAB | Q2 | -$1.01 | -$0.64 | -$0.53 | 17.19% | $0.00 | $7.85M | $10.95M | 39.50% | Get Alert |
| 05/06/2021 | PM | YMAB | Q1 | -$0.66 | $0.19 | $0.75 | 294.74% | $0.00 | $44.47M | $5.38M | -87.90% | Get Alert |
| 02/25/2021 | PM | YMAB | Q4 | -$0.61 | -$0.51 | -$0.48 | 5.88% | $0.00 | $15.54M | $20.75M | 33.53% | Get Alert |
| 11/05/2020 | PM | YMAB | Q3 | -$0.70 | -$0.79 | -$0.82 | -3.80% | $0.00 | — | $0.00 | — | Get Alert |
| 08/06/2020 | PM | YMAB | Q2 | -$0.53 | -$0.68 | -$1.01 | -48.53% | $0.00 | — | $0.00 | — | Get Alert |
| 05/07/2020 | PM | YMAB | Q1 | -$0.47 | -$0.62 | -$0.66 | -6.45% | $0.00 | — | $0.00 | — | Get Alert |
| 03/12/2020 | PM | YMAB | Q4 | -$0.42 | -$0.67 | -$0.61 | 8.96% | $0.00 | — | $0.00 | — | Get Alert |
| 11/13/2019 | PM | YMAB | Q3 | -$0.42 | -$0.55 | -$0.70 | -27.27% | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?
The Actual EPS was $-0.02, which beat the estimate of $-0.20.
What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?
The Actual Revenue was $23.4M, which beat the estimate of $20.9M.
Browse earnings estimates, EPS, and revenue on all stocks.